Lucknow Speciality Pharma

Ibrutinib Tablet 140 mg
This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. To get access, please contact Patient Support Team @ +91 9760014849 / 9555306364 / 9794360370 / 9140551027, Time 9 am - 8 pm IST or send us a request on email (urgent@lucknowpharma.com) / WhatsApp for the same.

Ibrutinib tablets was approved by the US Food and Drug Administration (FDA) on November 13, 2013, for the treatment of mantle cell lymphoma. On February 12, 2014, the FDA expanded the approved use of ibrutinib to chronic lymphocytic leukemia (CLL). It was approved for Waldenström’s macroglobulinemia in 2015.

Ibrutinib Tablet Available Price In Lucknow Banaras Nepal

Ibrutinib Tablet

  • Generic Brand Name – Ibrunat
  • Innovator Brand Name – Imbruvica
  • API – Ibrutinib
  • Packaging – 30 Capsules
  • Strength – 140 mg
  • Manufacturer Name – Natco Pharma

What is ibrutinib used for?

Ibrutinib tablets is a kinase inhibitor used for the treatment of adult patients with:

  • Mantle cell lymphoma (MCL)
  • Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL). 
  • Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL) with 17p deletion. 
  • Waldenström’s macroglobulinemia (WM). 
  • Marginal zone lymphoma (MZL). 
  • Chronic graft versus host disease (cGVHD). 

About Us

Lucknow Speciality Pharma is dedicated to delivering life-changing healthcare solutions. As a trusted wholesale supplier of specialized medicines, we cater to critical care areas such as oncology, nephrology, and rare diseases. Our patient-centric approach also includes personalized catering services, ensuring that patients receive the care, support, and nutrition they need to thrive. We also extend our services globally, welcoming international patients and buyers who seek our expertise and high-quality products.

Lucknow Speciality Pharma is a registered Pharmaceutical Firm in Lucknow, India. Registered under GST Act. Registration Number : 09AAOPG3102HIZY. It provide assistance and connectivity with drug pharmacies or distributors for access to genuine medicines at competitive prices. 

Get Access To Ibrutinib Tablet 140 mg

Enter Buying Requirements Details

For precise quotations, kindly ensure your requirements include the product name, order quantity, intended usage, and any special requests you may have.

Branch Offices in India : Lucknow | Agra | Varanasi | Gorakhpur | Kanpur | Indore | Patna | Kolkata | Nepal

FAQs – Medicine Questions

Ibrutinib Tablet 140 mg
From which class of drug Ibrutinib belongs?

Ibrutinib specifically belongs to the class of drugs named kinase inhibitors.

How much water should I consume with Ibrunat?

While taking Ibrunat 140 mg, consume at least 2-3 quarts of fluid in a day, unless you are instructed otherwise.

How should Ibrutinib be administered?

The recommended dose of ibrutinib tablet or capsules should be administered orally once daily at around the same time each day. Pills should be swallowed whole with water.

Where can I buy Ibrutinib Tablet?

You can buy Ibrutinib Tablet from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

The buyer should check the existing law in their home country before importing the product.

What is the procedure to buy Ibrutinib Tablet?

Patients can simply fill the order form or can send mail at info@lucknowpharma.com. Patients can also send WhatsApp messages to +91-9555306364 We will reply ASAP with the details of the Ibrutinib Tablet price as well as procurement procedure.

Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

NEWS / UPDATES

  1. Janssen-Cilag International Ltd, Electronic Medicines Compendium (EMC), [Revised on Jan 2021] [Accessed on 6th Jun 2021], https://www.medicines.org.uk/emc/files/pil.10040.pdf
  2. [Revised on Dec 2020] [Accessed on 6th Jun 2021], https://www.imbruvica.com/files/prescribing-information.pdf
  3. H.G. Watson, J.I.O. Craig, L.M. Manson, Blood disease, Davidson’s Principles and Practice of Medicine, 22nd Edition, 2014, 989-1056.
  4. Sapna Parmar, Khilna Patel, Javier Pinilla-Ibarz, Ibrutinib (Imbruvica): A Novel Targeted Therapy for Chronic Lymphocytic Leukemia, Drug Forecast, 2014, 39(7), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103574/pdf/ptj3907483.pdf